• Download mobile app
23 Mar 2018, Edition - 983, Friday


  • Reports have emerged that China has transferred a highly-sensitive missile technology to Pakistan
  • TDP reaches out to TRS, AIADMK, asks for their help in pushing for no-confidence motion in the Parliament.
  • Mallapuram, Kerala: 22 year old stabbed to death by her father on the eve of wedding; family opposed her wedding to the man
  • Kerala Professor Jouhar Munavvir booked over his derogatory remarks against women
  • Social activist Anna Hazare begins hunger strike in the national capital demanding Lokpal and better solution for farmers’ issues
  • Ballia, Uttar Pradesh: 15 year old ends life after police did not act seriously on her complaint about harassment by 5 men.
  • Bolt and Dortmund are both sponsored by Puma and the event was hence considered more of a publicity stunt
  • CM Naidu speaks to his MPs, tells TDP MPs to ‘keep fighting, don’t stop till A.P gets justice’, TDP keeps up pressure on centre
  • Mohammed Shami cleared by BCCI | Cricketer gets clean chit by Anti-corruption unit
  • Airtel scored the lowest score at 3.2 Mbps in Kanpur, while the lowest score by Idea Cellular was reported to be 2.6 Mbps in Bhiwani


Efforts on to develop Ebola and AIDS vaccines

Covai Post Network

A team of doctors, led by an Indian, is on the verge of developing a vaccine that would immunize the body against the deadly virus Ebola and AIDS. They have already positively tested the vaccine on mice and are now conducting human trials. The team is from the prestigious MD Anderson Cancer Centre in Houston, Texas, the U.S.

The vaccine is being developed from plants such as pasture grass, sunflower and beechnuts. These plants are commonly available all across the world.

“The studies have been approved by the Food and Drug Administration (FDA). The plant based extract produces antibodies in mice. This is a very good indicator that it might work in humans. Clinical trials are going on in humans. We can’t reveal much more than this as this is covered by Intellectual Property Rights,” said Rajagopal Appavu, who is the only Indian on the team of doctors.

Dr. Rajagopal completed his Ph.D. at the Indian Institute of Science in Bengaluru. He is from Salem and did his B.Sc. in Government Arts College, Salem, and M.Sc. in Pondicherry University. He is from Vazhapadi in Salem district.
“We are now studying the use of the extract to prevent cancer. The studies are going on since 2012,” the doctor said.

“We are developing peptide-based vaccine adjuvants that boost the immune system against infectious diseases,” Dr. Rajagopal, lead author of the paper ‘Enhancing the Magnitude of Antibody Responses through Biomaterial Stereochemistry’ was quoted by the Indian Science Journal, as saying. “All the peptides reported have toxicity under the acceptable limit,” he added.